Foundry Partners, LLC - PROGENICS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2016$67,000
-10.7%
10,600
-40.7%
0.00%0.0%
Q2 2016$75,000
-3.8%
17,8750.0%0.00%
-50.0%
Q1 2016$78,00017,8750.01%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
ARDSLEY ADVISORY PARTNERS LP 1,255,000$5,823,0001.12%
Phocas Financial Corp. 1,146,292$5,319,0000.54%
Worth Venture Partners, LLC 138,357$641,0000.36%
RICE HALL JAMES & ASSOCIATES, LLC 2,293,179$10,640,0000.34%
Monashee Investment Management LLC 240,000$1,114,0000.26%
BKS ADVISORS, LLC 118,587$550,0000.22%
PINNACLE ASSOCIATES LTD 1,418,391$6,581,0000.15%
FARALLON CAPITAL MANAGEMENT LLC 4,200,820$19,492,0000.15%
Fosun International Ltd 472,580$2,174,0000.14%
CARILLON TOWER ADVISERS, INC. 3,948,024$18,318,0000.13%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders